A Great Biotechnology Stock For A Growth Portfolio

Updated on Thursday, February 4, 2010 at 10:23AM by Jim Smith

Here is a biotechnology stock with 3 billion dollars in cash, owns all of its drugs and has no debt. It has a huge pipeline of more than 20 drugs in late stage trails during 2010.

Click to read more ...

Abbott Labs For Healthy Portfolio Gains

Updated on Tuesday, December 1, 2009 at 09:32AM by Jim Smith

Overview: Abbott Labs is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies.

Click to read more ...